About Inquis Medical
Inquis Medical is a company based in Redwood City (United States) founded in 2019. Inquis Medical has raised $115 million across 2 funding rounds from investors including Marshall Wace, ShangBay Capital and Yu Galaxy. Inquis Medical offers products and services including AVENTUS Thrombectomy System and AVENTUS Clot Management System. Inquis Medical operates in a competitive market with competitors including Orchestra BioMed, Biotronik, Spectrumedics, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others.
- Headquarter Redwood City, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$115 M (USD)
in 2 rounds
-
Latest Funding Round
$75 M (USD), Series C
Jan 12, 2026
-
Investors
Marshall Wace
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inquis Medical
Inquis Medical offers a comprehensive portfolio of products and services, including AVENTUS Thrombectomy System and AVENTUS Clot Management System.
Device for non-surgical removal of blood clots in vasculature.
System for autologous blood transfusion during procedures.
Funding Insights of Inquis Medical
Inquis Medical has successfully raised a total of $115M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Inquis Medical
Inquis Medical has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Marshall Wace, ShangBay Capital and Yu Galaxy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-short equity strategies are managed through specialized hedge funds.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital investments are made in innovative founders by Yu Galaxy.
|
Locked | Locked | Locked |
Investor details for Inquis Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inquis Medical
Investment portfolio details for Inquis Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Inquis Medical
Detailed financials for Inquis Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inquis Medical Comparisons
Peer comparison for Inquis Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Inquis Medical
Inquis Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchestra BioMed, Biotronik, Spectrumedics, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for hypertension and atherosclerosis treatment are developed.
|
|
| Locked | Locked | Locked |
Cardiovascular products and equipment are developed, manufactured, and distributed.
|
|
| Locked | Locked | Locked |
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification
|
|
| Locked | Locked | Locked |
Medical devices for cardiac arrhythmias and cardiovascular diseases are developed.
|
|
| Locked | Locked | Locked |
Extracorporeal circulation products including ECMO are developed for medical support.
|
Detailed competitors of Inquis Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inquis Medical
Complete news archive for Inquis Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inquis Medical
Inquis Medical was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Inquis Medical is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Vahid Saadat is the current CEO of Inquis Medical.
Inquis Medical is a funded company, having raised a total of $115M across 2 funding rounds to date.
Inquis Medical was founded in 2019 and is headquartered in Redwood City, United States. Focus is placed on the development of medical devices targeted at peripheral thrombectomy procedures within the healthcare sector. Operations involve engineering solutions for vascular interventions, with emphasis on device efficacy for clot removal. The company is led by CEO Vahid Saadat, and activities are conducted primarily in the United States medical device industry.
Inquis Medical's top competitors include Orchestra BioMed, Biotronik and Spectrumedics.
Inquis Medical offers AVENTUS Thrombectomy System and AVENTUS Clot Management System.
Inquis Medical has 5 investors. Key investors include Marshall Wace, ShangBay Capital, Yu Galaxy, Pierre Lamond, and EnPointe Ventures.